Experiments were conducted on Ripk1fl/fl and Ripk1LPC-KO mice undergoing CCl4-induced acute hepatitis with or without a pre-treatment with a FasL antagonist intraperitoneally administrated 1 h before CCl4 gavage. This evidence concerns the gene FASLG and Acute hepatitis.